18-23556436-A-G
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_000271.5(NPC1):c.1133T>C(p.Val378Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000383 in 1,461,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000271.5 missense
Scores
Clinical Significance
Conservation
Publications
- Niemann-Pick disease, type C1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Myriad Women’s Health
- Niemann-Pick disease type C, adult neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, juvenile neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, late infantile neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, severe early infantile neurologic onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Niemann-Pick disease type C, severe perinatal formInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000271.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPC1 | NM_000271.5 | MANE Select | c.1133T>C | p.Val378Ala | missense | Exon 8 of 25 | NP_000262.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NPC1 | ENST00000269228.10 | TSL:1 MANE Select | c.1133T>C | p.Val378Ala | missense | Exon 8 of 25 | ENSP00000269228.4 | ||
| NPC1 | ENST00000591051.1 | TSL:2 | c.413T>C | p.Val138Ala | missense | Exon 3 of 18 | ENSP00000467636.1 | ||
| NPC1 | ENST00000540608.5 | TSL:2 | n.1047T>C | non_coding_transcript_exon | Exon 6 of 16 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251252 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
DNA sequence analysis of the NPC1 gene demonstrated a sequence change, c.1133T>C, in exon 8 that results in an amino acid change, p.Val378Ala. The p.Val378Ala change affects a highly conserved amino acid residue located in a domain of the NPC1 protein that is known to be functional. Functional studies of this variant indicate that the variant resulted in an NPC1 protein that was blocked intracellularly in the ER (PMID: 30923329). In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Val378Ala substitution. This pathogenic sequence change has previously been described in the compound heterozygous state in multiple individuals with Niemann-Pick disease type C, some of whom had onset in adulthood (PMID: 32138288, 26666848). This sequence change has been described in the gnomAD database in two individuals which corresponds to a frequency of 0.0008% in the overall population (dbSNP rs120074134). The p.Val378Ala amino acid change occurs in a region of the NPC1 gene where other missense sequence changes have been described in individuals with NPC1-related disorders. Collectively, this evidence indicates that this sequence change is pathogenic.
Published functional studies demonstrate a damaging effect on glycosylation and cellular localization (Shammas et al., 2019); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22065762, 30923329, 31509197, 11333381, 26666848, 32138288, 26937389)
Niemann-Pick disease, type C1 Pathogenic:2
This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 378 of the NPC1 protein (p.Val378Ala). This variant is present in population databases (rs120074134, gnomAD 0.004%). This missense change has been observed in individual(s) with Niemann-Pick Type C (PMID: 11333381, 26666848, 26937389). ClinVar contains an entry for this variant (Variation ID: 2970). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects NPC1 function (PMID: 22065762, 30923329). For these reasons, this variant has been classified as Pathogenic.
Niemann-Pick disease, type C Pathogenic:1
Variant summary: NPC1 c.1133T>C (p.Val378Ala) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251252 control chromosomes. c.1133T>C has been reported in the literature in multiple individuals affected with Niemann-Pick Disease Type C (Millat_2001, Imrie_2015, Greenberg_2015). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, one study shows no impact on binding (Diffieu_2011) and another shows it is blocked intracellulary in the Endoplasmic Reticulum (Shammas_2019). The following publications have been ascertained in the context of this evaluation (PMID: 22065762, 26937389, 26666848, 11333381, 30923329). ClinVar contains an entry for this variant (Variation ID: 2970). Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at